EU to buy extra 100 million doses of Pfizer-BioNTech vaccine
Our Reporter
THE European Union (EU) will purchase an additional 100 million doses of the Pfizer-BioNTech COVID-19 vaccine, officials said on Tuesday, as the bloc of 27 nations has launched its effort to vaccinate its 450 million-person population.

The EU’s purchase comes as some vaccine candidates that the bloc has invested in have experienced delays during its trials, leading it to rely on the 200 million doses of the Pfizer-BioNTech vaccine that it originally purchased.